Literature DB >> 17180137

Myocardial cell therapy at the crossroads.

Bernardo Nadal-Ginard, Valentin Fuster.   

Abstract

Mesh：

Year:  2007        PMID： 17180137     DOI： 10.1038/ncpcardio0743

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN： 1743-4297


× No keyword cloud information.
  7 in total

Review 1.  Optimizing cardiac repair and regeneration through activation of the endogenous cardiac stem cell compartment.

Authors:  Georgina M Ellison; Bernardo Nadal-Ginard; Daniele Torella
Journal:  J Cardiovasc Transl Res       Date:  2012-06-12       Impact factor: 4.132

Review 2.  Immune response to stem cells and strategies to induce tolerance.

Authors:  Puspa Batten; Nadia A Rosenthal; Magdi H Yacoub
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-08-29       Impact factor: 6.237

Review 3.  Cellular therapies for heart disease: unveiling the ethical and public policy challenges.

Authors:  Amish N Raval; Timothy J Kamp; Linda F Hogle
Journal:  J Mol Cell Cardiol       Date:  2007-11-22       Impact factor: 5.000

4.  Use of arginine-glycine-aspartic acid adhesion peptides coupled with a new collagen scaffold to engineer a myocardium-like tissue graft.

Authors:  O Schussler; C Coirault; M Louis-Tisserand; W Al-Chare; P Oliviero; C Menard; R Michelot; P Bochet; D R Salomon; J C Chachques; A Carpentier; Y Lecarpentier
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 5.  Cell-based therapy in ischemic stroke.

Authors:  David C Hess; Cesar V Borlongan
Journal:  Expert Rev Neurother       Date:  2008-08       Impact factor: 4.618

6.  Bone marrow cell therapy after acute myocardial infarction. Back to bench, or ready for an outcome trial.

Authors:  Ketil Lunde
Journal:  J Cardiovasc Transl Res       Date:  2008-11-14       Impact factor: 4.132

Review 7.  Cardiac cell repair therapy: a clinical perspective.

Authors:  Bernard J Gersh; Robert D Simari; Atta Behfar; Carmen M Terzic; Andre Terzic
Journal:  Mayo Clin Proc       Date:  2009-10       Impact factor: 7.616
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.